Is Ponatinib available in Bangladesh?

Ponatinib (Ponatinib) has a Bangladeshi version, which belongs to the category of generic drugs. Its pharmaceutical ingredients are basically the same as those of the original drug of Ponatinib, but the price is different due to different manufacturers. Ponatinib, the original drug, was originally produced and sold by Ariad Pharmaceuticals and can be made into oral tablets.

Chronic myeloid leukemia (CML), a cancer characterized by uncontrolled growth of white blood cells in the bone marrow, currently receives first-line treatment with nilotinib and/or dasatinib, but 22-33% of patients discontinue treatment within two years due to adverse events, treatment failure and other reasons. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) is a more aggressive subtype of leukemia than CML. Ponatinib is a multi-target tyrosine kinase inhibitor that targets the oncogenic BCR-ABL gene, which produces the BCR-ABL protein. The drug can also shrink tumors expressing native or T315I mutant BCR-ABL.

The original drug of Ponatinib has not yet been launched in China, so it is not included in the medical insurance. Domestic patients in need may only purchase it through overseas channels. The Hong Kong original version of Ponatinib specificationsThe price of 45mg*30 tablets per box may be around 40,000 yuan (the price may fluctuate due to the exchange rate), which is expensive. The price of generic ponatinib is relatively cheap. The price of 45mg*30 tablets per box produced by Bangladesh Everest Pharmaceuticals may be around 4,000 RMB. The price of 45mg*30 tablets produced by Bangladesh Beacon Pharmaceutical may be around 5,000 RMB per box (the price may fluctuate due to the exchange rate). For specific prices and drug information, please consult Yaode Medical Consultant.